Federal Register: October 21, 2005 (Volume 70, Number 203)
DOCID: FR Doc 05-21068
DEPARTMENT OF DEFENSE
Army Department
NOTICE: NOTICES
ACTION: Patent licenses; non-exclusive, exclusive, or partially exclusive:
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patents and Patent Applications Concerning Bacterial Superantigen Vaccines
DOCUMENT SUMMARY:
In accordance with 37 CFR 404.6 and 404.7, announcement is made
[[Page 61262]]
of the availability for licensing of U.S. Patent No. 6,399,332 entitled
``Bacterial Superantigen Vaccines,'' issued June 4, 2002; U.S. Patent
No. 6,713,284 entitled ``Bacterial Superantigen Vaccines,'' issued
March 30, 2004; U.S. Patent Application No. 10/757,687 entitled
``Bacterial Superantigen Vaccines,'' filed January 29, 2004, which is a
divisional of U.S. Patent No. 6,713,284; and U.S. Patent Application
No. 10/002,784 entitled ``Bacterial Superantigen Vaccines,'' filed
November 26, 2001, which is a continuation in part of U.S. Patent No.
6,713,284. Foreign rights are also available (PCT/US98/16766 and PCT/
US01/46540). The United States Government, as represented by the
Secretary of the Army, has rights in this invention.
SUMMARY:
Bacterial superantigen vaccines,
SUPPLEMENTAL INFORMATION
The present invention relates to genetically
attenuated superantigen toxin vaccines altered such that superantigen
attributes are absent, however the superantigen is effectively
recognized and an appropriate immune response is produced. The
attenuated superantigen toxins are shown to protect animals against
challenge with wild type toxin. Methods of producing and using the altered superantigen toxins are described.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 0521068 Filed 102005; 8:45 am]
BILLING CODE 371008M
FOR FURTHER INFORMATION CONTACT
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 6196664, both at telefax (301) 6195034.